Aim: To explore the potential emotional and behavioural impact of providing information on personalised genomic risk to the public, using melanoma as an example, to aid research translation. Methods: We conducted four focus groups in which 34 participants were presented with a hypothetical scenario of an individual’s lifetime genomic risk of melanoma (using the term ‘genetic risk’). We asked about understanding of genetic risk, who would choose to receive this risk information, potential emotional and behavioural impacts, and other concerns or potential benefits. Data were analysed thematically. Results: Participants thought this risk information could potentially motivate preventive behaviours such as sun protection, and related it to scr...
BACKGROUND: Personalized genomic risk information has the potential to motivate behaviour change and...
Abstract: There is currently great interest in using genetic risk estimates for common disease in pe...
Background: As part of a pilot randomised controlled trial examining the impact of personal melanoma...
Aim: To explore the potential emotional and behavioural impact of providing information on personali...
BACKGROUND: There is a need for greater understanding of the spectrum of emotional and behavioural r...
Background: Personalized genomic risk information has the potential to motivate behaviour change and...
Purpose We evaluated the impact of personal melanoma genomic risk information on sun-related behavio...
Background: Communication of personalized melanoma genomic risk information may improve melanoma pre...
PURPOSE: We evaluated the impact of personal melanoma genomic risk information on sun-related behavi...
There is currently great interest in using genetic risk estimates for common disease in personalized...
Purpose: We evaluated the impact of personal melanoma genomic risk information on sun-related behavi...
BACKGROUND: Communication of personalized melanoma genomic risk information may improve melanoma pre...
Purpose: We evaluated the impact of personal melanoma genomic risk information on sun-related behavi...
BACKGROUND: Receiving information about genomic risk of melanoma might trigger conversations about s...
New genomic technologies are increasingly used in both the clinical and research settings to stratif...
BACKGROUND: Personalized genomic risk information has the potential to motivate behaviour change and...
Abstract: There is currently great interest in using genetic risk estimates for common disease in pe...
Background: As part of a pilot randomised controlled trial examining the impact of personal melanoma...
Aim: To explore the potential emotional and behavioural impact of providing information on personali...
BACKGROUND: There is a need for greater understanding of the spectrum of emotional and behavioural r...
Background: Personalized genomic risk information has the potential to motivate behaviour change and...
Purpose We evaluated the impact of personal melanoma genomic risk information on sun-related behavio...
Background: Communication of personalized melanoma genomic risk information may improve melanoma pre...
PURPOSE: We evaluated the impact of personal melanoma genomic risk information on sun-related behavi...
There is currently great interest in using genetic risk estimates for common disease in personalized...
Purpose: We evaluated the impact of personal melanoma genomic risk information on sun-related behavi...
BACKGROUND: Communication of personalized melanoma genomic risk information may improve melanoma pre...
Purpose: We evaluated the impact of personal melanoma genomic risk information on sun-related behavi...
BACKGROUND: Receiving information about genomic risk of melanoma might trigger conversations about s...
New genomic technologies are increasingly used in both the clinical and research settings to stratif...
BACKGROUND: Personalized genomic risk information has the potential to motivate behaviour change and...
Abstract: There is currently great interest in using genetic risk estimates for common disease in pe...
Background: As part of a pilot randomised controlled trial examining the impact of personal melanoma...